Analyst Ratings For NASDAQ:CLLS – Cellectis (NASDAQ:CLLS)

Today, Oppenheimer raised its price target on NASDAQ:CLLS – Cellectis (NASDAQ:CLLS) to per share.

Some recent analyst ratings include

• 3/16/2018-Guggenheim initiated coverage with a Neutral ➝ Neutral rating.
• 10/29/2017-Jefferies Financial Group Reiterated Rating of Buy.
• 10/6/2017-SunTrust Banks Reiterated Rating of Hold.
• 9/5/2017-Wells Fargo & Co Reiterated Rating of Outperform ➝ Outperform.
• 3/1/2017-Instinet initiated coverage with a Buy ➝ Buy rating.

Recent Trading Activity for NASDAQ:CLLS – Cellectis (NASDAQ:CLLS)
Shares of NASDAQ:CLLS – Cellectis closed the previous trading session at 30.53 up +0.32 1.06% with 30.610000610351562 shares trading hands.